Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:adjuvant |
AS03
|
| gptkbp:clinical_trial |
Phase 3
|
| gptkbp:collaborated_with |
gptkb:Sanofi
|
| gptkbp:developed_by |
gptkb:Glaxo_Smith_Kline
|
| https://www.w3.org/2000/01/rdf-schema#label |
GSK's COVID-19 vaccine
|
| gptkbp:is_effective_against |
approximately 70%
|
| gptkbp:regulatory_compliance |
Emergency Use Authorization
|
| gptkbp:route_of_administration |
intramuscular
|
| gptkbp:targets |
gptkb:COVID-19
|
| gptkbp:type |
subunit vaccine
|
| gptkbp:bfsParent |
gptkb:Lonza_Group
|
| gptkbp:bfsLayer |
6
|